Cannabis Bioscience Files 253G2
Ticker: CBIH · Form: 253G2 · Filed: Apr 15, 2026 · CIK: 0001411057
| Field | Detail |
|---|---|
| Company | Cannabis Bioscience International Holdings, INC. (CBIH) |
| Form Type | 253G2 |
| Filed Date | Apr 15, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, disclosure
TL;DR
CBIH filed a 253G2 on 4/15/26. Check for updates.
AI Summary
Cannabis Bioscience International Holdings, Inc. filed a Form 253G2 on April 15, 2026. The filing pertains to the company's operations and regulatory disclosures. The company's mailing and business address is 6201 Bonhomme Road, Suite 435S, Houston, TX 77036.
Why It Matters
This filing indicates ongoing regulatory compliance and operational updates for Cannabis Bioscience International Holdings, Inc. Investors and interested parties should review the document for details on the company's status.
Risk Assessment
Risk Level: low — A 253G2 filing is a routine regulatory submission and does not inherently indicate significant risk.
Key Players & Entities
- Cannabis Bioscience International Holdings, Inc. (company) — Filer
- 0001411057 (company) — CIK
- 6201 BONHOMME ROAD SUITE 435S HOUSTON TX 77036 (address) — Mailing and Business Address
- 2026-04-15 (date) — Filing Date
FAQ
What type of filing is this?
This is a Form 253G2 filing.
Who is the filer?
The filer is Cannabis Bioscience International Holdings, Inc.
When was the filing accepted?
The filing was accepted on April 15, 2026.
What is the company's CIK number?
The company's CIK number is 0001411057.
What is the company's business address?
The company's business address is 6201 Bonhomme Road, Suite 435S, Houston, TX 77036.
Filing Details
This Form 253G2 (Form 253G2) was filed with the SEC on April 15, 2026 regarding Cannabis Bioscience International Holdings, Inc. (CBIH).